Table 3.

Incidence of Adverse Events in Various Systems and Organs

System Organ Types, n(%)	Treatment Group (n=47)	Control Group (n=44)	P
Overall	26(55.32)	21(47.72)	0.61
Various inspections	20(42.55)	18(40.90)	0.87
Epileptiform discharge	1(2.12)	0(0.00)	0.33
T-wave change	1(2.12)	0(0.00)	0.33
Short PR interval	1(2.12)	0(0.00)	0.33
Complete right bundle branch block	1(2.12)	0(0.00)	0.33
Disease of respiratory system	22(46.80)	21(47.72)	0.77
Fever	18(38.30)	18(40.90)	0.97
Nasal congestion	4(8.51)	0(0.00)	0.14
Cough	13(27.66)	15(34.09)	0.66
Runny nose	6(12.76)	8(18.18)	0.67
Pant	3(6.38)	2(4.55)	0.70
Sore throat	3(6.38)	0(0.00)	0.26
Various reactions on the skin and at the site of administration	1(2.12)	0(0.00)	0.33
Transient skin flushing	1(2.12)	0(0.00)	0.33
Slightly pale complexion	1(2.12)	0(0.00)	0.33
Skin rash	1(2.12)	0(0.00)	0.33
Nervous system disease	1(2.12)	0(0.00)	0.33
Convulsion	1(2.12)	1(2.27)	0.96
Delayed myelin development	1(2.12)	1(2.27)	0.96
Subdural effusion	1(2.12)	0(0.00)	0.33
Systemic diseases	1(2.12)	0(0.00)	0.33
Poor appetite	1(2.12)	1(2.27)	0.96
Edema	1(2.12)	0(0.0)	0.33
Listlessness	1(2.12)	0(0.0)	0.33
Gastrointestinal system diseases	1(2.12)	0(0.0)	0.33
Vomit	2(4.26)	1(2.27)	0.60
Diarrhea	1(2.12)	1(2.27)	0.96